Medications: Medications that can cause low platelets include: Thrombocytopenia can be genetic, which means it is passed down ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

Prithviraj Bose, MD, discusses the most critical adverse effects seen with each of the 4 approved JAK inhibitors for the treatment of myeloproliferative neoplasms.

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced upcoming presentations of six posters highlighting data from their ...

Treatments include switching medications, platelet exchange or transfusion, and splenectomy. National Heart, Lung, and Blood Institute. Platelet disorders - thrombocytopenia. Moses S. Family Practice ...

A number of factors could cause actual results to differ materially ... will be approved for marketing by the U.S. Food and Drug Administration, European Medicines Agency, PRC National Medical ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

Appointed Douglas Williams, Ph.D. as Chair of the Board of DirectorsFDA Clearance of Investigational New Drug Application (IND) for systemic ...

Sandra Lesenfants, senior vice president of Abbott’s Structural Heart business, shares an update on MitraClip, TriClip, and ...

Group 3 (21 patients): acute renal insufficiency from a variety of causes ... thrombocytopenia. The patients in Group 3 were in general the most toxic, since septicemia and drug intoxication ...